aTyr Pharma Inc (NASDAQ:LIFE)

18.85
Delayed Data
As of Jun 29
 -0.81 / -4.12%
Today’s Change
12.90
Today|||52-Week Range
28.29
-60.52%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 42.00, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +122.81% increase from the last price of 18.85.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.51
Sales
$0.00
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 94.56%
 
 
 
Growthannually 36.09%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account